Two phase 2b studies in atopic dermatitis and alopecia areata reported positive outcomes, demonstrating clinically meaningful efficacy based on speaker comments and explicit transcript references.

Hello, and thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...